Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for November 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Dry Eye Found to Have Negative Impact on Prolonged Reading
THURSDAY, Nov. 29, 2018 (HealthDay News) — Dry eye seems to have a significant negative impact on prolonged reading, according to a study published online Nov. 15 in Optometry and Vision Science.
Amblyopia Linked to Lower Self-Perception in Children
WEDNESDAY, Nov. 28, 2018 (HealthDay News) — Children with amblyopia report lower self-perception for scholastic, social, and athletic measures, which may be associated with slower reading speed and worse motor skills, according to a study published online Nov. 15 in JAMA Ophthalmology.
FDA to Update Medical Device Approvals Process
TUESDAY, Nov. 27, 2018 (HealthDay News) — A major update of the United States’ system for approving medical devices was announced yesterday by the Food and Drug Administration.
Four Principles Underlie Patient and Family Partnership in Care
TUESDAY, Nov. 27, 2018 (HealthDay News) — Patient and family partnership in care should include treatment of patients and families with dignity and respect, their active engagement in all aspects of care, and their contribution to the improvement of health care systems and education of health care professionals, according to a position paper published online Nov. 27 in the Annals of Internal Medicine.
ACA Coverage Substantial, but Did Not Impact Labor Markets
MONDAY, Nov. 26, 2018 (HealthDay News) — Millions of workers gained insurance coverage under the Affordable Care Act (ACA) without adverse effects on labor markets, according to a report published by the Robert Wood Johnson Foundation and the Urban Institute.
CDC: 8.8 Percent Uninsured in U.S. in First Half of 2018
FRIDAY, Nov. 16, 2018 (HealthDay News) — In the first six months of 2018, 8.8 percent of U.S. individuals of all ages were uninsured, which was not significantly different from 2017, according to a report published Nov. 15 by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.
Name-Brand Medications Driving Spike in U.S. Drug Spending
THURSDAY, Nov. 15, 2018 (HealthDay News) — Rising drug spending in the United States is being fueled by expensive name-brand prescription medicines, a new study shows.
Calcified Nodules in Drusen May Signal Progression of AMD